PRTK - Paratek Pharmaceuticals, Inc.

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Show:
Income statement
Cash flow
Annual

Balance sheet

All numbers in thousands
Breakdown
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Assets
Current assets
Cash
Cash and cash equivalents
34,248
80,367
105,157
102,302
Other short-term investments
0
15,107
20,005
113,077
Total cash
34,248
95,474
125,162
215,379
Net receivables
74,657
29,438
11,878
8,475
Inventory
16,565
11,020
14,555
11,579
Other current assets
7,866
12,364
7,776
6,489
Total current assets
136,842
152,100
164,117
243,354
Non-current assets
Property, plant and equipment
Gross property, plant and equipment
4,874
4,814
5,761
6,077
Accumulated depreciation
-2,476
-2,263
-2,787
-2,336
Net property, plant and equipment
2,398
2,551
2,974
3,741
Goodwill
829
829
829
829
Other long-term assets
32,469
28,389
8,933
3,155
Total non-current assets
35,696
31,769
12,736
7,725
Total assets
172,538
183,869
176,853
251,079
Liabilities and stockholders' equity
Liabilities
Current liabilities
Accounts payable
5,308
5,394
1,813
4,116
Accrued liabilities
10,316
7,499
9,614
7,624
Other current liabilities
870
2,457
1,314
3,388
Total current liabilities
37,388
31,297
23,953
24,200
Non-current liabilities
Long-term debt
256,946
254,428
250,474
260,728
Other long-term liabilities
2,453
2,777
3,142
3,703
Total non-current liabilities
306,192
280,359
255,160
266,526
Total liabilities
343,580
311,656
279,113
290,726
Stockholders' equity
Common stock
56
52
705,535
671,537
Retained earnings
-930,449
-866,883
-807,799
-711,258
Accumulated other comprehensive income
0
-9
4
74
Total stockholders' equity
-171,042
-127,787
-102,264
-39,721
Total liabilities and stockholders' equity
172,538
183,869
176,853
251,079